![COX-2 inhibitors / Medicine / Pharmacy / Rofecoxib / Sulfones / Pharmaceutical industry / Direct-to-consumer advertising / Valdecoxib / Prescription medication / Pharmaceuticals policy / Pharmacology / Pharmaceutical sciences COX-2 inhibitors / Medicine / Pharmacy / Rofecoxib / Sulfones / Pharmaceutical industry / Direct-to-consumer advertising / Valdecoxib / Prescription medication / Pharmaceuticals policy / Pharmacology / Pharmaceutical sciences](/pdf-icon.png)
| Document Date: 2013-10-22 11:08:54 Open Document File Size: 31,00 KBShare Result on Facebook
City Ottawa / / Country United States / New Zealand / Canada / / Facility University of Manitoba / / IndustryTerm pharmaceutical industry / prescription pharmaceuticals / drug advertising / / MedicalCondition cancer / disease / stroke / heart disease / / Organization University of Manitoba / Centre for Professional and Applied Ethics / Medicare / / Person Arthur Schafer / / Position Director / / Product Viagra / Vioxx / Bextra / / ProvinceOrState Manitoba / /
SocialTag |